M+W Group appointed to build £55m gene therapy centre

摘要

M+W Group has been appointed to deliver a £55m manufacturing centre for cell and gene therapy products. The centre in Stevenage Bioscience Catalyst campus is being developed by Cell Therapy Catapult. Completion is expected in 2017. Cell Therapy Catapult chief executive Keith Thompson said: "The manufacturing centre will provide global scientific and medical communities with the assistance they need to convert research into products that have the potential to have a direct impact in advanced healthcare."